SlideShare ist ein Scribd-Unternehmen logo
1 von 31
Downloaden Sie, um offline zu lesen
Applicant Town Hall
August 2013 Cycle
May 22, 2013
1
Agenda
Introductions
About PCORI
Improving Healthcare Systems Overview
Elements of PCORI Funded Research
Merit Review Criteria
Administrative Considerations
Resources
Live Q&A
Submitting Questions:
Submit questions via the
chat function in Meeting
Bridge.
Ask a question via phone
(an operator will standby to
take your questions).
2
Introductions
Martin Duenas, MPA
Contracts Director
Geri Guman, MBA
Contracts Administrator
James Hulbert
Contracts Administrator
Soknorntha Prum, MPH
Contracts Coordinator
3
Chad Boult, MD, MPH
Program Director
Shiva Chittari, Ph.D.
Scientific Review Officer
Lev Nevo, M.D.
Scientific Review Officer
About PCORI
4
PCORI’s Mission and Vision
 The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit health
research organization authorized by the Patient Protection and Affordable Care Act of 2010.
 PCORI funds patient-centered research to assist patients, caregivers, and other stakeholders in
making informed health decisions.
Mission
PCORI helps people make
informed healthcare
decisions and improves
healthcare delivery and
outcomes by producing and
promoting high integrity,
evidence-based information
that comes from research
guided by patients,
caregivers, and the broader
healthcare community.
Vision
Patients and the public have
the information they need to
make decisions that reflect
their desired health
outcomes.
5
Research Done Differently
PCORI’s unique contribution to this field of research is its dedicated focus on outcomes that matter
most to patients.
Inclusion of patient-centered outcomes is therefore a
necessary component of PCORI-funded research.
PCORI involves patients and the entire healthcare
community in every step of the research
process — from selecting research questions to study,
to the actual conduct of research, to sharing the
research findings through platforms and channels that
are accessible to everyone.
6
Focus on Comparative Clinical
Effectiveness Research
PCORI focuses on comparative clinical effectiveness research (CER), studies that compare “health
outcomes and the clinical effectiveness, risks, and benefits of two or more medical” treatments or
services.
Our mandate is to support comparative clinical effectiveness research, which compares the success
of two or more available options.
For example, this could include
comparing any treatment or drug
used to treat a patient. It could
also mean comparing different
health systems or methods of
delivering care to patients.
7
PCORI’s Key Criteria for Funding
 Potential for Improvement - How likely is the proposed research to lead
changes in patient or clinician practices that lead in turn to meaningful
improvement in patient health?
 Patient-Centeredness - Is the proposed research focused on comparisons and
outcomes that matter to patients and their caregivers?
 Patient and Stakeholder Engagement - Have the researchers included in their
team relevant patients and other key healthcare community members,
representative of those who would use its information?
8
Non-Responsive Studies to PCORI
Directly compares the costs of care between two or
more alternative approaches as the criteria for choosing
the preferred alternative.
Conducts a formal cost-effectiveness analysis in the
form of dollar-cost per quality-adjusted life-year
(including non-adjusted life-years) to compare two or
more alternatives.
Applications to this Program will be considered non-responsive if research is
proposed that:
9
PCORI Funding Announcements
10
Overview of PFAs
To solicit research proposals, PCORI regularly releases funding announcements that invite researchers
to submit applications to receive funding to conduct research projects:
Addressing Disparities
Assessment of Prevention, Diagnosis, and Treatment Options
Communication and Dissemination Research
Improving Healthcare Systems
Improving Methods for Conducting Patient-Centered Outcomes Research
11
Improving Healthcare Systems
12
Improving Healthcare Systems
In this PFA, we are interested in proposals for research on:
 Innovations in the deployment of personnel
 Applications of IT
 The effects of incentives
 Special clinical programs
Our focus is on improvements in PCOs and systems’
efficiency.
Available funds: Up To $16 Million
13
Sample Research Questions
The following research questions are meant as examples of the types of questions that your
research may help answer:
 An 84-year-old woman with several chronic diseases is having increasing difficulties
managing at home alone, but does not want to leave her home or neighborhood for a
nursing home. What are the benefits and drawbacks of different programs or services that
might help her stay at home and remain independent safely? Which should she choose?
 A 27-year-old man with diabetes, chronic back pain, and depression has been invited by his
public hospital-based clinic to participate in a group visit program for patients with chronic
conditions led by a behavioral care specialist and a health educator. How likely is it that he
will benefit from this program compared to the “usual” care he receives now, and what is the
nature of the benefit? What should his primary care physician recommend?
 An elderly man has been hospitalized four times in the past year for congestive heart failure.
One challenge seems to be related to delays and poor communication during the transition
from the hospital back to the primary care doctor. What could the hospital do to help this
man reduce his chances of being re-hospitalized? What could this primary care system do?
14
Merit Review Criteria
15
Merit Review Criteria
Applicants must respond to the five PCORI Merit Review Criteria.
1. Impact of the condition on
the health of individuals and
populations
2. Potential for study to
improve healthcare and
outcomes
3. Technical Merit 4. Patient-centeredness
5. Patient and stakeholder
engagement
16
Criterion 1: Impact of the condition on
the health of individuals and
populations
Refers to inclusion of the following:
 Is the condition or disease associated with a significant burden in the US population, in
terms of prevalence, mortality, morbidity, individual suffering, or loss of productivity?
 Does it impose a significant burden on a smaller number of people who have a rare disease?
 A particular emphasis is on patients with chronic conditions, including those patients with
multiple chronic conditions.
17
Criterion 2: Potential for the study to
improve healthcare and outcomes
Refers to the potential for the proposed research to lead to meaningful improvement in the
quality and efficiency of care and to improvements in outcomes that are important to patients.
Does the research question address a critical gap in current knowledge as noted in
systematic reviews, guideline development efforts, or previous research prioritizations?
Has it been identified as important by patient, caregiver, or clinician groups?
Do wide variations in practice patterns suggest current clinical uncertainty?
Is the research novel or innovative in its methods or approach, in the population being
studied, or in the intervention being evaluated, in ways that make it likely to improve care?
Do preliminary studies indicate potential for a sizeable benefit of the intervention relative to
current practice?
How likely is it that positive findings could be disseminated quickly and effect changes in
current practice?
18
Criterion 3: Technical merit
Refers to inclusion of the following:
Clear research plan with rigorous methods and key milestones clearly articulated
Research Team has appropriate expertise and project organizational structure is appropriate
for the study
Research Environment is sufficient to support conduct of the work; appropriate resources
are available.
Includes diverse population with respect to age, gender, race, ethnicity, and clinical status as
appropriate for the study
Focuses on defined population for whom effectiveness information is particularly needed
19
Criterion 4: Patient-centeredness
Refers to inclusion of the following:
Is the proposed research focused on questions that affect outcomes of specific interest to
patients and their caregivers?
Does the research address one or more of the key questions mentioned in PCORI’s definition
of patient-centered outcomes research?
20
Criterion 5: Patient and
stakeholder engagement
Refers to inclusion of the following:
Does the proposal describe how patients and other stakeholders were or will be identified
and engaged in the research?
What are the roles of patients and other key stakeholders in formulating the study’s
hypotheses and design and in the study’s conduct and dissemination of results?
What roles do patients and stakeholders have in any planned dissemination or
implementation plans?
Applications need to demonstrate patient and stakeholder engagement through the
integration of patients and stakeholders in the development of the research plan and in key
elements of the proposed project including:
Participate in formulating research questions
Define essential characteristics of the study, participants, comparators and outcomes
Monitoring study conduct and progress
Participate in disseminating findings through multiple outlets
If the project has not included patient and stakeholder engagement (for example, in the area of
analytic methods), has the application justified their non-inclusions? If engagement is not
applicable, explain why it is not. 21
Letter of Intent (LOI) and
Administrative Considerations
22
Understanding the Letter of Intent (LOI)
An LOI is required in order to submit an
application.
LOI’s are NOT scored.
Applicants will NOT receive an invitation to
submit an application after submitting a LOI.
An Investigator can only be listed as a PI on
one.
Of note: PCORI encourages applicants to submit their LOI and application before
the stated due date. LOIs and applications are due 5:00 pm ET.
23
Eligibility Requirements
Applications may be submitted by:
 Any private sector research organization, including any:
• non-profit organization
• for-profit organization
 Any public sector research organization, including any:
• university or college
• hospital or healthcare system
• Laboratory or manufacture
• unit of state or local government
 Foreign Organizations
 Nondomestic Components of Organizations based in the United States
Please Note: Individuals are not eligible to submit applications to PCORI.
24
Budget and Period Limitations
Budget
• Maximum $500,000 direct costs per year
• Indirect costs are capped at 40%
• *Request for exception can be made during the LOI submission
Period of Performance
• Maximum of three years
• PCORI encourages projects of shorter duration
• *Request for exception can be made during the LOI submission
*Of note: Approval or denial decisions may take up to four months. Please plan accordingly, and
factor this into your decision to submit a request.
25
Key Dates: August 15 2013
Key Dates: PCORI Funding Announcements
Action Cycle I
System Opening Date May 15
Letter of Intent (LOI) Due
Date
June 15
Informational Training
Programs
July – August
Application Deadline August 15
Merit Review Dates September - November
Awards Announced December / January
Earliest Start Date January
26
Frequently Asked Questions (FAQS)
27
Frequently Asked Questions
(Programmatic)
How do I know if my research is of interest to PCORI?
 We encourage you to read the PCORI Funding Announcements (PFAs) carefully and other
background material on our website to understand our goals and the PFA you are
considering.
Can I speak with someone at PCORI about the suitability of my research question?
 Currently, PCORI does not have dedicated individuals to speak with applicants regarding
submission questions. Applicants and potential applicants with questions should submit
those inquiries via pfa@pcori.org. We will respond within 48 hours.
Is there a specific disease or condition that is a priority for PCORI?
 No. PCORI is concerned with patient outcomes, across a range of conditions and
treatments. PCORI will periodically issue PFAs that focus on specific diseases or conditions
within or across funding areas.
28
Frequently Asked Questions
(Administrative)
Can I switch PFAs after a LOI has been submitted?
 No. It is not possible to submit an LOI to one funding announcement and the full
application to another.
How much can the research proposed in my application differ from that initially described in
my Letter of Intent (LOI)?
 The information provided in the LOI, including the study title, may be changed in the final
application. Only two things may not differ:
• The PFA may not change
• The budget may not exceed direct cost and/or project period, as listed within the
PFA, if permission was not requested at LOI submission.
Can I list a different PI in the final application than was listed in the Letter of Intent (LOI)?
 Yes. The PI listed on your final application may differ from the PI listed in the LOI.
29
Resources
View training materials through the
Quick Links for Applicants bar. Access:
• Application training
• Opportunities for webinars
• Reviewer training
Visit the Funding Center for:
• PFAs
• Templates
• Instructions
• Key dates
• FAQ’s
30
Questions
Submitting Questions:
Submit questions via the chat
function in Meeting Bridge.
Ask a question via phone (an
operator will standby to take
your questions).
Please use this time to ask any question
you may have about the PFA or the LOI
submission process
If we are unable to address your question
during this time, e-mail the help desk at
pfa@pcori.org.
31

Weitere ähnliche Inhalte

Was ist angesagt?

What are the essential design features of personal health records to improve ...
What are the essential design features of personal health records to improve ...What are the essential design features of personal health records to improve ...
What are the essential design features of personal health records to improve ...Elisavet Andrikopoulou
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPM Society
 
September 2015 - How do hospitalists perceive effectiveness of QI strategies
September 2015 - How do hospitalists perceive effectiveness of QI strategiesSeptember 2015 - How do hospitalists perceive effectiveness of QI strategies
September 2015 - How do hospitalists perceive effectiveness of QI strategiesVandad Yousefi MD, CCFP, FHM
 
Gorter et al TRACE main paper BMJ Open May 2015
Gorter et al TRACE main paper BMJ Open May 2015Gorter et al TRACE main paper BMJ Open May 2015
Gorter et al TRACE main paper BMJ Open May 2015Oksana Hlyva
 
Outcomes research ppt
Outcomes research pptOutcomes research ppt
Outcomes research pptBernie Blanks
 
Supporting medicines adherence developing the pharmacist contribution
Supporting medicines adherence   developing the pharmacist contributionSupporting medicines adherence   developing the pharmacist contribution
Supporting medicines adherence developing the pharmacist contributionPM Society
 
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Marion Sills
 
Does family therapy for adolescent behavior problems work in the real world
Does family therapy for adolescent behavior problems work in the real worldDoes family therapy for adolescent behavior problems work in the real world
Does family therapy for adolescent behavior problems work in the real worldCenter on Addiction
 
Week 12 ppt research
Week 12 ppt researchWeek 12 ppt research
Week 12 ppt researchShalee Belnap
 
SPEP Student Transition of Care Project
SPEP Student Transition of Care ProjectSPEP Student Transition of Care Project
SPEP Student Transition of Care ProjectPASaskatchewan
 
SBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
SBIRT As A Harm Reduction Public Health Approach for At-Risk College StudentsSBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
SBIRT As A Harm Reduction Public Health Approach for At-Risk College StudentsKaren V. Duhamel
 
SBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
SBIRT As A Harm Reduction Public Health Approach for At-Risk College StudentsSBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
SBIRT As A Harm Reduction Public Health Approach for At-Risk College StudentsKaren V. Duhamel
 
Outcomes research
Outcomes researchOutcomes research
Outcomes researchTony Ngo
 

Was ist angesagt? (20)

What are the essential design features of personal health records to improve ...
What are the essential design features of personal health records to improve ...What are the essential design features of personal health records to improve ...
What are the essential design features of personal health records to improve ...
 
Ebp in pcc
Ebp in pccEbp in pcc
Ebp in pcc
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
 
September 2015 - How do hospitalists perceive effectiveness of QI strategies
September 2015 - How do hospitalists perceive effectiveness of QI strategiesSeptember 2015 - How do hospitalists perceive effectiveness of QI strategies
September 2015 - How do hospitalists perceive effectiveness of QI strategies
 
Outcomes research
Outcomes researchOutcomes research
Outcomes research
 
Gorter et al TRACE main paper BMJ Open May 2015
Gorter et al TRACE main paper BMJ Open May 2015Gorter et al TRACE main paper BMJ Open May 2015
Gorter et al TRACE main paper BMJ Open May 2015
 
Outcomes research ppt
Outcomes research pptOutcomes research ppt
Outcomes research ppt
 
Supporting medicines adherence developing the pharmacist contribution
Supporting medicines adherence   developing the pharmacist contributionSupporting medicines adherence   developing the pharmacist contribution
Supporting medicines adherence developing the pharmacist contribution
 
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
 
Does family therapy for adolescent behavior problems work in the real world
Does family therapy for adolescent behavior problems work in the real worldDoes family therapy for adolescent behavior problems work in the real world
Does family therapy for adolescent behavior problems work in the real world
 
Advances in the Management of Moderate to Severe Atopic Dermatitis: How Can W...
Advances in the Management of Moderate to Severe Atopic Dermatitis: How Can W...Advances in the Management of Moderate to Severe Atopic Dermatitis: How Can W...
Advances in the Management of Moderate to Severe Atopic Dermatitis: How Can W...
 
Week 12 ppt research
Week 12 ppt researchWeek 12 ppt research
Week 12 ppt research
 
SPEP Student Transition of Care Project
SPEP Student Transition of Care ProjectSPEP Student Transition of Care Project
SPEP Student Transition of Care Project
 
SBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
SBIRT As A Harm Reduction Public Health Approach for At-Risk College StudentsSBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
SBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
 
SBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
SBIRT As A Harm Reduction Public Health Approach for At-Risk College StudentsSBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
SBIRT As A Harm Reduction Public Health Approach for At-Risk College Students
 
Outcomes research
Outcomes researchOutcomes research
Outcomes research
 
Week 12 assignment
Week 12 assignmentWeek 12 assignment
Week 12 assignment
 
Gender and Health
Gender and HealthGender and Health
Gender and Health
 
Ileana research ppt wk 12
Ileana research ppt wk 12Ileana research ppt wk 12
Ileana research ppt wk 12
 
Patient and Clinician Views on Comparative Effectiveness Research and Engagem...
Patient and Clinician Views on Comparative Effectiveness Research and Engagem...Patient and Clinician Views on Comparative Effectiveness Research and Engagem...
Patient and Clinician Views on Comparative Effectiveness Research and Engagem...
 

Ähnlich wie PFA Applicant Town Hall Improving Healthcare Systems

Cadth 2015 a5 1 pt engage symp marshall cadth apr 13 2015 present
Cadth 2015 a5 1  pt engage symp marshall cadth apr 13 2015 presentCadth 2015 a5 1  pt engage symp marshall cadth apr 13 2015 present
Cadth 2015 a5 1 pt engage symp marshall cadth apr 13 2015 presentCADTH Symposium
 
Pcori hickam ucsf 1 16 2014 ver 2
Pcori hickam ucsf 1 16 2014 ver 2Pcori hickam ucsf 1 16 2014 ver 2
Pcori hickam ucsf 1 16 2014 ver 2CTSI at UCSF
 
Global issues 12.5.13
Global issues 12.5.13Global issues 12.5.13
Global issues 12.5.13dbrown2014
 
Weitzman 2013: PCORI: Transforming Health Care
Weitzman 2013: PCORI: Transforming Health CareWeitzman 2013: PCORI: Transforming Health Care
Weitzman 2013: PCORI: Transforming Health CareCHC Connecticut
 
Romana Hasnain-Wynia: Incorporating the Patient’s Perspective in Research
Romana Hasnain-Wynia: Incorporating the Patient’s Perspective in ResearchRomana Hasnain-Wynia: Incorporating the Patient’s Perspective in Research
Romana Hasnain-Wynia: Incorporating the Patient’s Perspective in ResearchNIHACS2015
 
Levels of Engagement and Appropriate Methods
Levels of Engagement and Appropriate MethodsLevels of Engagement and Appropriate Methods
Levels of Engagement and Appropriate MethodsCHICommunications
 
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptx
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptxCCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptx
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptxCanadian Cancer Survivor Network
 
Evaluation of health services
Evaluation of health servicesEvaluation of health services
Evaluation of health serviceskavita yadav
 
UCSF CER - What PCORI Wants (Symposium 2013)
UCSF CER - What PCORI Wants (Symposium 2013)UCSF CER - What PCORI Wants (Symposium 2013)
UCSF CER - What PCORI Wants (Symposium 2013)CTSI at UCSF
 
Cadth 2015 a5 3 cadth panel pauline mc nulty april 2015 no notes
Cadth 2015 a5 3 cadth panel pauline mc nulty april 2015 no notesCadth 2015 a5 3 cadth panel pauline mc nulty april 2015 no notes
Cadth 2015 a5 3 cadth panel pauline mc nulty april 2015 no notesCADTH Symposium
 
Key Stakeholders in Public Health Issue.docx
Key Stakeholders in Public Health Issue.docxKey Stakeholders in Public Health Issue.docx
Key Stakeholders in Public Health Issue.docx4934bk
 
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...Effective Health Care Program
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...Todd Berner MD
 
Healthy People 2020Healthy People was a call to action and an.docx
Healthy People 2020Healthy People  was a call to action and an.docxHealthy People 2020Healthy People  was a call to action and an.docx
Healthy People 2020Healthy People was a call to action and an.docxpooleavelina
 

Ähnlich wie PFA Applicant Town Hall Improving Healthcare Systems (20)

PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Out...
PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Out...PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Out...
PFA Applicant Town Hall Improving Methods for Conducting Patient-Centered Out...
 
Cadth 2015 a5 1 pt engage symp marshall cadth apr 13 2015 present
Cadth 2015 a5 1  pt engage symp marshall cadth apr 13 2015 presentCadth 2015 a5 1  pt engage symp marshall cadth apr 13 2015 present
Cadth 2015 a5 1 pt engage symp marshall cadth apr 13 2015 present
 
Latino Roundtable Discussion
Latino Roundtable Discussion Latino Roundtable Discussion
Latino Roundtable Discussion
 
Pcori hickam ucsf 1 16 2014 ver 2
Pcori hickam ucsf 1 16 2014 ver 2Pcori hickam ucsf 1 16 2014 ver 2
Pcori hickam ucsf 1 16 2014 ver 2
 
Global issues 12.5.13
Global issues 12.5.13Global issues 12.5.13
Global issues 12.5.13
 
Weitzman 2013: PCORI: Transforming Health Care
Weitzman 2013: PCORI: Transforming Health CareWeitzman 2013: PCORI: Transforming Health Care
Weitzman 2013: PCORI: Transforming Health Care
 
Romana Hasnain-Wynia: Incorporating the Patient’s Perspective in Research
Romana Hasnain-Wynia: Incorporating the Patient’s Perspective in ResearchRomana Hasnain-Wynia: Incorporating the Patient’s Perspective in Research
Romana Hasnain-Wynia: Incorporating the Patient’s Perspective in Research
 
National Priorities and Research Agenda
National Priorities and Research AgendaNational Priorities and Research Agenda
National Priorities and Research Agenda
 
Levels of Engagement and Appropriate Methods
Levels of Engagement and Appropriate MethodsLevels of Engagement and Appropriate Methods
Levels of Engagement and Appropriate Methods
 
Improving the Impact of Patient-Engaged Research
Improving the Impact of Patient-Engaged ResearchImproving the Impact of Patient-Engaged Research
Improving the Impact of Patient-Engaged Research
 
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptx
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptxCCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptx
CCSN Webinar Patient Input into HTA Decision Making Oct 5 2023.pptx
 
Evaluation of health services
Evaluation of health servicesEvaluation of health services
Evaluation of health services
 
UCSF CER - What PCORI Wants (Symposium 2013)
UCSF CER - What PCORI Wants (Symposium 2013)UCSF CER - What PCORI Wants (Symposium 2013)
UCSF CER - What PCORI Wants (Symposium 2013)
 
Cadth 2015 a5 3 cadth panel pauline mc nulty april 2015 no notes
Cadth 2015 a5 3 cadth panel pauline mc nulty april 2015 no notesCadth 2015 a5 3 cadth panel pauline mc nulty april 2015 no notes
Cadth 2015 a5 3 cadth panel pauline mc nulty april 2015 no notes
 
Key Stakeholders in Public Health Issue.docx
Key Stakeholders in Public Health Issue.docxKey Stakeholders in Public Health Issue.docx
Key Stakeholders in Public Health Issue.docx
 
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
 
Role of Patient Engagement in Healthcare Decision Making!
Role of Patient Engagement in Healthcare Decision Making!Role of Patient Engagement in Healthcare Decision Making!
Role of Patient Engagement in Healthcare Decision Making!
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
 
Healthy People 2020Healthy People was a call to action and an.docx
Healthy People 2020Healthy People  was a call to action and an.docxHealthy People 2020Healthy People  was a call to action and an.docx
Healthy People 2020Healthy People was a call to action and an.docx
 
How Prescription Drugs are Approved in Canada
How Prescription Drugs are Approved in CanadaHow Prescription Drugs are Approved in Canada
How Prescription Drugs are Approved in Canada
 

Mehr von Patient-Centered Outcomes Research Institute

Mehr von Patient-Centered Outcomes Research Institute (20)

New Patient-Centered Study on Preventing Fall-Related Injuries in Older Adults
New Patient-Centered Study on Preventing Fall-Related Injuries in Older AdultsNew Patient-Centered Study on Preventing Fall-Related Injuries in Older Adults
New Patient-Centered Study on Preventing Fall-Related Injuries in Older Adults
 
From Research to Practice: New Models for Data-sharing and Collaboration to I...
From Research to Practice: New Models for Data-sharing and Collaboration to I...From Research to Practice: New Models for Data-sharing and Collaboration to I...
From Research to Practice: New Models for Data-sharing and Collaboration to I...
 
Advisory Panel on Improving Healthcare Systems Spring 2014 Meeting
Advisory Panel on Improving Healthcare Systems Spring 2014 MeetingAdvisory Panel on Improving Healthcare Systems Spring 2014 Meeting
Advisory Panel on Improving Healthcare Systems Spring 2014 Meeting
 
Advisory Panel on Clinical Trials Spring 2014 Meeting
Advisory Panel on Clinical Trials Spring 2014 MeetingAdvisory Panel on Clinical Trials Spring 2014 Meeting
Advisory Panel on Clinical Trials Spring 2014 Meeting
 
Advisory Panel on Advisory Panel on Assessment of Prevention, Diagnosis, and ...
Advisory Panel on Advisory Panel on Assessment of Prevention, Diagnosis, and ...Advisory Panel on Advisory Panel on Assessment of Prevention, Diagnosis, and ...
Advisory Panel on Advisory Panel on Assessment of Prevention, Diagnosis, and ...
 
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 1
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 1Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 1
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 1
 
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 2
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 2Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 2
Advisory Panel on Patient Engagement Spring 2014 Meeting: Day 2
 
Advisory Panel on Addressing Disparities Spring 2014 Meeting
Advisory Panel on Addressing Disparities Spring 2014 MeetingAdvisory Panel on Addressing Disparities Spring 2014 Meeting
Advisory Panel on Addressing Disparities Spring 2014 Meeting
 
Combined Meeting of the Spring 2014 Advisory Panels on Patient Engagement and...
Combined Meeting of the Spring 2014 Advisory Panels on Patient Engagement and...Combined Meeting of the Spring 2014 Advisory Panels on Patient Engagement and...
Combined Meeting of the Spring 2014 Advisory Panels on Patient Engagement and...
 
Advisory Panel on Rare Disease Spring 2014 Meeting
Advisory Panel on Rare Disease Spring 2014 MeetingAdvisory Panel on Rare Disease Spring 2014 Meeting
Advisory Panel on Rare Disease Spring 2014 Meeting
 
PCORnet: Building Evidence through Innovation and Collaboration
PCORnet: Building Evidence through Innovation and CollaborationPCORnet: Building Evidence through Innovation and Collaboration
PCORnet: Building Evidence through Innovation and Collaboration
 
PCORnet: Building Evidence through Innovation and Collaboration
PCORnet: Building Evidence through Innovation and CollaborationPCORnet: Building Evidence through Innovation and Collaboration
PCORnet: Building Evidence through Innovation and Collaboration
 
Patient-Powered Research Network Workshop
Patient-Powered Research Network WorkshopPatient-Powered Research Network Workshop
Patient-Powered Research Network Workshop
 
Patient-Powered Research Network Workshop
Patient-Powered Research Network WorkshopPatient-Powered Research Network Workshop
Patient-Powered Research Network Workshop
 
Seeking Input on Future PROMIS® Research: Educating Patients and Stakeholders...
Seeking Input on Future PROMIS® Research: Educating Patients and Stakeholders...Seeking Input on Future PROMIS® Research: Educating Patients and Stakeholders...
Seeking Input on Future PROMIS® Research: Educating Patients and Stakeholders...
 
Launching the Eugene Washington PCORI Engagement Awards Program
Launching the Eugene Washington PCORI Engagement Awards ProgramLaunching the Eugene Washington PCORI Engagement Awards Program
Launching the Eugene Washington PCORI Engagement Awards Program
 
Promising Practices of Meaningful Engagement in the Conduct of Research
Promising Practices of Meaningful Engagement in the Conduct of ResearchPromising Practices of Meaningful Engagement in the Conduct of Research
Promising Practices of Meaningful Engagement in the Conduct of Research
 
PCORI Merit Review: Learning from Patients, Scientists and other Stakeholders
PCORI Merit Review: Learning from Patients, Scientists and other StakeholdersPCORI Merit Review: Learning from Patients, Scientists and other Stakeholders
PCORI Merit Review: Learning from Patients, Scientists and other Stakeholders
 
Opening a Pipeline to Patient-Centered Research Proposals
Opening a Pipeline to Patient-Centered Research ProposalsOpening a Pipeline to Patient-Centered Research Proposals
Opening a Pipeline to Patient-Centered Research Proposals
 
Special Board of Governors Teleconference/Webinar
Special Board of Governors Teleconference/WebinarSpecial Board of Governors Teleconference/Webinar
Special Board of Governors Teleconference/Webinar
 

Kürzlich hochgeladen

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxraviapr7
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxAkshay Shetty
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 

Kürzlich hochgeladen (20)

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Musculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptxMusculoskeletal disorders: Osteoarthritis,.pptx
Musculoskeletal disorders: Osteoarthritis,.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Hypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptxHypersensitivity and its classification .pptx
Hypersensitivity and its classification .pptx
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 

PFA Applicant Town Hall Improving Healthcare Systems

  • 1. Applicant Town Hall August 2013 Cycle May 22, 2013 1
  • 2. Agenda Introductions About PCORI Improving Healthcare Systems Overview Elements of PCORI Funded Research Merit Review Criteria Administrative Considerations Resources Live Q&A Submitting Questions: Submit questions via the chat function in Meeting Bridge. Ask a question via phone (an operator will standby to take your questions). 2
  • 3. Introductions Martin Duenas, MPA Contracts Director Geri Guman, MBA Contracts Administrator James Hulbert Contracts Administrator Soknorntha Prum, MPH Contracts Coordinator 3 Chad Boult, MD, MPH Program Director Shiva Chittari, Ph.D. Scientific Review Officer Lev Nevo, M.D. Scientific Review Officer
  • 5. PCORI’s Mission and Vision  The Patient-Centered Outcomes Research Institute (PCORI) is an independent, non-profit health research organization authorized by the Patient Protection and Affordable Care Act of 2010.  PCORI funds patient-centered research to assist patients, caregivers, and other stakeholders in making informed health decisions. Mission PCORI helps people make informed healthcare decisions and improves healthcare delivery and outcomes by producing and promoting high integrity, evidence-based information that comes from research guided by patients, caregivers, and the broader healthcare community. Vision Patients and the public have the information they need to make decisions that reflect their desired health outcomes. 5
  • 6. Research Done Differently PCORI’s unique contribution to this field of research is its dedicated focus on outcomes that matter most to patients. Inclusion of patient-centered outcomes is therefore a necessary component of PCORI-funded research. PCORI involves patients and the entire healthcare community in every step of the research process — from selecting research questions to study, to the actual conduct of research, to sharing the research findings through platforms and channels that are accessible to everyone. 6
  • 7. Focus on Comparative Clinical Effectiveness Research PCORI focuses on comparative clinical effectiveness research (CER), studies that compare “health outcomes and the clinical effectiveness, risks, and benefits of two or more medical” treatments or services. Our mandate is to support comparative clinical effectiveness research, which compares the success of two or more available options. For example, this could include comparing any treatment or drug used to treat a patient. It could also mean comparing different health systems or methods of delivering care to patients. 7
  • 8. PCORI’s Key Criteria for Funding  Potential for Improvement - How likely is the proposed research to lead changes in patient or clinician practices that lead in turn to meaningful improvement in patient health?  Patient-Centeredness - Is the proposed research focused on comparisons and outcomes that matter to patients and their caregivers?  Patient and Stakeholder Engagement - Have the researchers included in their team relevant patients and other key healthcare community members, representative of those who would use its information? 8
  • 9. Non-Responsive Studies to PCORI Directly compares the costs of care between two or more alternative approaches as the criteria for choosing the preferred alternative. Conducts a formal cost-effectiveness analysis in the form of dollar-cost per quality-adjusted life-year (including non-adjusted life-years) to compare two or more alternatives. Applications to this Program will be considered non-responsive if research is proposed that: 9
  • 11. Overview of PFAs To solicit research proposals, PCORI regularly releases funding announcements that invite researchers to submit applications to receive funding to conduct research projects: Addressing Disparities Assessment of Prevention, Diagnosis, and Treatment Options Communication and Dissemination Research Improving Healthcare Systems Improving Methods for Conducting Patient-Centered Outcomes Research 11
  • 13. Improving Healthcare Systems In this PFA, we are interested in proposals for research on:  Innovations in the deployment of personnel  Applications of IT  The effects of incentives  Special clinical programs Our focus is on improvements in PCOs and systems’ efficiency. Available funds: Up To $16 Million 13
  • 14. Sample Research Questions The following research questions are meant as examples of the types of questions that your research may help answer:  An 84-year-old woman with several chronic diseases is having increasing difficulties managing at home alone, but does not want to leave her home or neighborhood for a nursing home. What are the benefits and drawbacks of different programs or services that might help her stay at home and remain independent safely? Which should she choose?  A 27-year-old man with diabetes, chronic back pain, and depression has been invited by his public hospital-based clinic to participate in a group visit program for patients with chronic conditions led by a behavioral care specialist and a health educator. How likely is it that he will benefit from this program compared to the “usual” care he receives now, and what is the nature of the benefit? What should his primary care physician recommend?  An elderly man has been hospitalized four times in the past year for congestive heart failure. One challenge seems to be related to delays and poor communication during the transition from the hospital back to the primary care doctor. What could the hospital do to help this man reduce his chances of being re-hospitalized? What could this primary care system do? 14
  • 16. Merit Review Criteria Applicants must respond to the five PCORI Merit Review Criteria. 1. Impact of the condition on the health of individuals and populations 2. Potential for study to improve healthcare and outcomes 3. Technical Merit 4. Patient-centeredness 5. Patient and stakeholder engagement 16
  • 17. Criterion 1: Impact of the condition on the health of individuals and populations Refers to inclusion of the following:  Is the condition or disease associated with a significant burden in the US population, in terms of prevalence, mortality, morbidity, individual suffering, or loss of productivity?  Does it impose a significant burden on a smaller number of people who have a rare disease?  A particular emphasis is on patients with chronic conditions, including those patients with multiple chronic conditions. 17
  • 18. Criterion 2: Potential for the study to improve healthcare and outcomes Refers to the potential for the proposed research to lead to meaningful improvement in the quality and efficiency of care and to improvements in outcomes that are important to patients. Does the research question address a critical gap in current knowledge as noted in systematic reviews, guideline development efforts, or previous research prioritizations? Has it been identified as important by patient, caregiver, or clinician groups? Do wide variations in practice patterns suggest current clinical uncertainty? Is the research novel or innovative in its methods or approach, in the population being studied, or in the intervention being evaluated, in ways that make it likely to improve care? Do preliminary studies indicate potential for a sizeable benefit of the intervention relative to current practice? How likely is it that positive findings could be disseminated quickly and effect changes in current practice? 18
  • 19. Criterion 3: Technical merit Refers to inclusion of the following: Clear research plan with rigorous methods and key milestones clearly articulated Research Team has appropriate expertise and project organizational structure is appropriate for the study Research Environment is sufficient to support conduct of the work; appropriate resources are available. Includes diverse population with respect to age, gender, race, ethnicity, and clinical status as appropriate for the study Focuses on defined population for whom effectiveness information is particularly needed 19
  • 20. Criterion 4: Patient-centeredness Refers to inclusion of the following: Is the proposed research focused on questions that affect outcomes of specific interest to patients and their caregivers? Does the research address one or more of the key questions mentioned in PCORI’s definition of patient-centered outcomes research? 20
  • 21. Criterion 5: Patient and stakeholder engagement Refers to inclusion of the following: Does the proposal describe how patients and other stakeholders were or will be identified and engaged in the research? What are the roles of patients and other key stakeholders in formulating the study’s hypotheses and design and in the study’s conduct and dissemination of results? What roles do patients and stakeholders have in any planned dissemination or implementation plans? Applications need to demonstrate patient and stakeholder engagement through the integration of patients and stakeholders in the development of the research plan and in key elements of the proposed project including: Participate in formulating research questions Define essential characteristics of the study, participants, comparators and outcomes Monitoring study conduct and progress Participate in disseminating findings through multiple outlets If the project has not included patient and stakeholder engagement (for example, in the area of analytic methods), has the application justified their non-inclusions? If engagement is not applicable, explain why it is not. 21
  • 22. Letter of Intent (LOI) and Administrative Considerations 22
  • 23. Understanding the Letter of Intent (LOI) An LOI is required in order to submit an application. LOI’s are NOT scored. Applicants will NOT receive an invitation to submit an application after submitting a LOI. An Investigator can only be listed as a PI on one. Of note: PCORI encourages applicants to submit their LOI and application before the stated due date. LOIs and applications are due 5:00 pm ET. 23
  • 24. Eligibility Requirements Applications may be submitted by:  Any private sector research organization, including any: • non-profit organization • for-profit organization  Any public sector research organization, including any: • university or college • hospital or healthcare system • Laboratory or manufacture • unit of state or local government  Foreign Organizations  Nondomestic Components of Organizations based in the United States Please Note: Individuals are not eligible to submit applications to PCORI. 24
  • 25. Budget and Period Limitations Budget • Maximum $500,000 direct costs per year • Indirect costs are capped at 40% • *Request for exception can be made during the LOI submission Period of Performance • Maximum of three years • PCORI encourages projects of shorter duration • *Request for exception can be made during the LOI submission *Of note: Approval or denial decisions may take up to four months. Please plan accordingly, and factor this into your decision to submit a request. 25
  • 26. Key Dates: August 15 2013 Key Dates: PCORI Funding Announcements Action Cycle I System Opening Date May 15 Letter of Intent (LOI) Due Date June 15 Informational Training Programs July – August Application Deadline August 15 Merit Review Dates September - November Awards Announced December / January Earliest Start Date January 26
  • 28. Frequently Asked Questions (Programmatic) How do I know if my research is of interest to PCORI?  We encourage you to read the PCORI Funding Announcements (PFAs) carefully and other background material on our website to understand our goals and the PFA you are considering. Can I speak with someone at PCORI about the suitability of my research question?  Currently, PCORI does not have dedicated individuals to speak with applicants regarding submission questions. Applicants and potential applicants with questions should submit those inquiries via pfa@pcori.org. We will respond within 48 hours. Is there a specific disease or condition that is a priority for PCORI?  No. PCORI is concerned with patient outcomes, across a range of conditions and treatments. PCORI will periodically issue PFAs that focus on specific diseases or conditions within or across funding areas. 28
  • 29. Frequently Asked Questions (Administrative) Can I switch PFAs after a LOI has been submitted?  No. It is not possible to submit an LOI to one funding announcement and the full application to another. How much can the research proposed in my application differ from that initially described in my Letter of Intent (LOI)?  The information provided in the LOI, including the study title, may be changed in the final application. Only two things may not differ: • The PFA may not change • The budget may not exceed direct cost and/or project period, as listed within the PFA, if permission was not requested at LOI submission. Can I list a different PI in the final application than was listed in the Letter of Intent (LOI)?  Yes. The PI listed on your final application may differ from the PI listed in the LOI. 29
  • 30. Resources View training materials through the Quick Links for Applicants bar. Access: • Application training • Opportunities for webinars • Reviewer training Visit the Funding Center for: • PFAs • Templates • Instructions • Key dates • FAQ’s 30
  • 31. Questions Submitting Questions: Submit questions via the chat function in Meeting Bridge. Ask a question via phone (an operator will standby to take your questions). Please use this time to ask any question you may have about the PFA or the LOI submission process If we are unable to address your question during this time, e-mail the help desk at pfa@pcori.org. 31